Städtisches Klinikum Dessau

S3-Guideline: Diagnosis and Therapy of Hepatocellular Carcinoma (2022) Sabrina V, Michael B, Joerg A, Peter B, Wolf B, Susanne B, Thomas B, et al. Journal article Dokumentation der Psoriasis in der Routineversorgung – Expertenkonsens zu einem deutschen Datensatz (2021) Otten M, Mrowietz U, von Kiedrowski RM, Otto R, Altenburg A, Aschoff R, Beissert S, et al. Journal article Polatuzumab vedotin as a salvage and bridging treatment in relapsed or refractory large B-cell lymphomas (2021) Liebers N, Duell J, Fitzgerald D, Kerkhoff A, Noerenberg D, Kaebisch E, Acker F, et al. Journal article Stereotactic or conformal radiotherapy for adrenal metastases: Patient characteristics and outcomes in a multicenter analysis (2021) Buergy D, Wuerschmidt F, Gkika E, Hoerner-Rieber J, Knippen S, Gerum S, Balermpas P, et al. Journal article NTRK Testing Practice in German Pathologies (2021) Weyerer V, Ortiz-Bruechle N, Demes M, Schildgen O, Haybaeck J, Westphal G, Sander P, et al. Conference contribution Stereotactic or intensity modulated Radiotherapy of adrenal Metastases - Patient Characteristics and Therapy Results of a multicenter Analysis (2020) Buergy D, Wuerschmidt F, Gkika E, Hoerner-Rieber J, Knippen S, Gerum S, Balermpas P, et al. Conference contribution Dose Escalation and local Control after stereotactic Radiotherapy of adrenal Metastases of the Non-Small Cell Lung Carcinoma (NSCLC) - A multicenter Analysis (2020) Buergy D, Wurschmidt F, Hoerner-Rieber J, Gkika E, Knippen S, Gerum S, Balermpas P, et al. Conference contribution Mir-155-5p and mir-203a-3p are prognostic factors in soft tissue sarcoma (2020) Greither T, Koser F, Holzhausen HJ, Güttler A, Würl P, Kappler M, Wach S, Taubert H Journal article Prognosis of Patients With Stage III Melanoma According to American Joint Committee on Cancer Version 8: A Reassessment on the Basis of 3 Independent Stage III Melanoma Cohorts (2020) Garbe C, Keim U, Suciu S, Amaral T, Eigentler TK, Gesierich A, Hauschild A, et al. Journal article Cetuximab, fluorouracil and cisplatin with or without docetaxel for patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (CeFCiD): an open-label phase II randomised trial (AIO/IAG-KHT trial 1108) (2019) Klinghammer K, Gauler T, Dietz A, Grünwald V, Stöhlmacher J, Knipping S, Schroeder M, et al. Journal article